Intelligent Investor

Antisense Therapeutics Limited (ASX: ANP) - Announcements

Current share price for ANP : $0.058 0.003 (4.92%)

ASX company news and announcements for Antisense Therapeutics Limited (ANP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Antisense Therapeutics Limited (ANP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Antisense Therapeutics Limited (ANP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Antisense Therapeutics Limited (ANP)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
$52 Potential New Treatment for Growth & Sight Disorders 24 Feb 2004 10:40AM $0.145 $0.058 $0.059 fallen by 60%
$52 Half Yearly Report & Half Year Accounts 12 Feb 2004 4:39PM $0.125 $0.058 $0.059 fallen by 53.60%
$52 Commitments Test Entity - First Quarter Report 20 Oct 2003 10:43AM $0.140 $0.058 $0.059 fallen by 58.57%
$52 Preliminary Final Report/Full Year Accounts 22 Aug 2003 2:18PM $0.180 $0.058 $0.059 fallen by 67.78%
$52 Placement 20 Aug 2003 10:00AM $0.165 $0.058 $0.059 fallen by 64.85%
$52 Trading Halt 18 Aug 2003 9:55AM n/a $0.058 $0.059 n/a
$52 Trading Halt 18 Aug 2003 9:55AM n/a $0.058 $0.059 n/a

701 - 707 of 707 results

Page 29 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.